Stable Isotope Labelled Plozalizumab Biosimilar – Anti-CCR2/CD192 mAb – Research Grade

Reference: PX-TA1395-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Plozalizumab Biosimilar - Anti-CCR2/CD192 mAb - Research Grade
SourceCAS 1610761-46-0
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsMLN-1202,anti-CCR2,hu1D9
ReferencePX-TA1395-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Plozalizumab Biosimilar - Anti-CCR2/CD192 mAb - Research Grade

General information on Anti-CCR2/CD192[Homo sapiens] (Plozalizumab) Monoclonal Antibody

Plozalizumab is a humanized monoclonal antibody that targets CCR2 chemokine receptors found on the surface of white blood cells such as macrophages and monocytes. Plozalizumab has been investigated to treat Atherosclerosis. CCR2 is supposed to play an important role in the trafficking of monocytes and macrophages to sites of inflammation.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Plozalizumab Biosimilar – Anti-CCR2/CD192 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (3 Items)

    size:

    100ug

    Availability: In Stock
    1 × $309.00
    Size:

    100ug

    Availability: In Stock
    1 × $361.00
    size:

    100ug

    Availability: In Stock
    1 × $452.00